In 264 European registry patients with atopic dermatitis given baricitinib, a pooled 62% (95% CI 50–73%) reached EASI≤7 at week 13/16; mean EASI change −7.8. Itch response varied widely across registries (NRS≤4: 20% to 71%).
Meta-analysisn = 264
Boesjes et al. A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany